Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Upstream Bio (UPB) Accumulated Expenses: 2023-2024

Historic Accumulated Expenses for Upstream Bio (UPB) over the last 2 years, with Dec 2024 value amounting to $6.0 million.

  • Upstream Bio's Accumulated Expenses rose 36.68% to $7.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $7.2 million, marking a year-over-year increase of 36.68%. This contributed to the annual value of $6.0 million for FY2024, which is 33.75% up from last year.
  • Per Upstream Bio's latest filing, its Accumulated Expenses stood at $6.0 million for FY2024, which was up 33.75% from $4.5 million recorded in FY2023.
  • In the past 5 years, Upstream Bio's Accumulated Expenses registered a high of $6.0 million during FY2024, and its lowest value of $4.5 million during FY2023.
  • Over the past 2 years, Upstream Bio's median Accumulated Expenses value was $5.2 million (recorded in 2023), while the average stood at $5.2 million.
  • Data for Upstream Bio's Accumulated Expenses shows a peak YoY skyrocketed of 33.75% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Upstream Bio's Accumulated Expenses stood at $4.5 million in 2023, then spiked by 33.75% to $6.0 million in 2024.